Using young blood to stop aging is not the best idea



Of course, many of us are worried about aging, looking for a fountain of youth, whether it's Oil Of Olay in the pharmacy aisle or showing our neck to a hunky vampire. The Washington Post reports that some people are actually looking for "young blood" treatments – "plasma infusions of young donors marketed for diseases such as Parkinson's disease, Alzheimer's disease, multiple sclerosis and Parkinson's syndrome." post-traumatic stress". Scott Gottlieb and Peter Marks, director of evaluation and research at the FDA's Center for Biologics, firmly claim that the use of a young plasma to compensate for the diseases of older people Has no proven value.

Bloomberg reports that this strange practice has gained ground with billionaire Peter Thiel, appeared on an episode of Silicon Valley, and is offered by a franchise called Ambrosia, "which has offices in five US states and sells a liter of blood plasma to donors aged 16 to 25 for $ 8,000". To post Ambrosia's note announced "that" in accordance with "the FDA's statement, she had ceased patient treatments".

On the one hand, if you put everything on the side and squint very hard, you can almost see how some people might have clung to this practice in the first place; after all, blood transfusions can be helpful in medical procedures, right? On the other hand, this idea seems not only banana, but downright macabre. Fighting time is useless and aging is certainly better than the other option. If you are still patented from time to time, we will tell you that everything is fine. No need to know everything about Transylvania.


Source link